Table S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy Article Swipe
Matheus Henrique Dias
,
Anoek Friskes
,
Siying Wang
,
João M. Fernandes Neto
,
Frank van Gemert
,
Soufiane Mourragui
,
Chrysa Papagianni
,
Hendrik J. Kuiken
,
Sara Mainardi
,
Daniel Álvarez‐Villanueva
,
Cor Lieftink
,
Ben Morris
,
Anna Dekker
,
Emma van Dijk
,
Lieke H.S. Wilms
,
Marcelo S. da Silva
,
Robin A. Jansen
,
Antonio Mulero‐Sánchez
,
Elke Malzer
,
August Vidal
,
Cristina Santos
,
Ramón Salazar
,
Rosangela A.M. Wailemann
,
Thompson E.P. Torres
,
Giulia De Conti
,
Jonne A. Raaijmakers
,
Pétur Snæbjörnsson
,
Shengxian Yuan
,
Wenxin Qin
,
John S. Kovach
,
Hugo A. Armelin
,
Hein te Riele
,
Alexander van Oudenaarden
,
Haojie Jin
,
Roderick L. Beijersbergen
,
Alberto Villanueva
,
René H. Medema
,
René Bernards
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.26134819
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.26134819
Supplementary table 6: Stress-focused drug screens AUC differences in SW-480 cells Area Under the Curve (AUC) from each compound of the stress-focused drug screen in the presence or absence of LB-100. Compounds are ranked by the difference in the AUC between LB-100-treated and untreated samples.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2159-8290.26134819
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4400213820
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4400213820Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2159-8290.26134819Digital Object Identifier
- Title
-
Table S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment StrategyWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-07-01Full publication date if available
- Authors
-
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M. Fernandes Neto, Frank van Gemert, Soufiane Mourragui, Chrysa Papagianni, Hendrik J. Kuiken, Sara Mainardi, Daniel Álvarez‐Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H.S. Wilms, Marcelo S. da Silva, Robin A. Jansen, Antonio Mulero‐Sánchez, Elke Malzer, August Vidal, Cristina Santos, Ramón Salazar, Rosangela A.M. Wailemann, Thompson E.P. Torres, Giulia De Conti, Jonne A. Raaijmakers, Pétur Snæbjörnsson, Shengxian Yuan, Wenxin Qin, John S. Kovach, Hugo A. Armelin, Hein te Riele, Alexander van Oudenaarden, Haojie Jin, Roderick L. Beijersbergen, Alberto Villanueva, René H. Medema, René BernardsList of authors in order
- Landing page
-
https://doi.org/10.1158/2159-8290.26134819Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2159-8290.26134819Direct OA link when available
- Concepts
-
Table (database), Area under the curve, Drug, Pharmacology, Area under curve, Internal medicine, Cancer research, Oncology, Medicine, Chemistry, Pharmacokinetics, Computer science, DatabaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4400213820 |
|---|---|
| doi | https://doi.org/10.1158/2159-8290.26134819 |
| ids.doi | https://doi.org/10.1158/2159-8290.26134819 |
| ids.openalex | https://openalex.org/W4400213820 |
| fwci | 0.0 |
| type | preprint |
| title | Table S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12996 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9635999798774719 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1305 |
| topics[0].subfield.display_name | Biotechnology |
| topics[0].display_name | Cancer Research and Treatments |
| topics[1].id | https://openalex.org/T12626 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9621000289916992 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2738 |
| topics[1].subfield.display_name | Psychiatry and Mental health |
| topics[1].display_name | Cancer, Stress, Anesthesia, and Immune Response |
| topics[2].id | https://openalex.org/T10631 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.949400007724762 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Cancer, Hypoxia, and Metabolism |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C45235069 |
| concepts[0].level | 2 |
| concepts[0].score | 0.5015311241149902 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q278425 |
| concepts[0].display_name | Table (database) |
| concepts[1].id | https://openalex.org/C76318530 |
| concepts[1].level | 2 |
| concepts[1].score | 0.49828052520751953 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q16833590 |
| concepts[1].display_name | Area under the curve |
| concepts[2].id | https://openalex.org/C2780035454 |
| concepts[2].level | 2 |
| concepts[2].score | 0.45641687512397766 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[2].display_name | Drug |
| concepts[3].id | https://openalex.org/C98274493 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4397064745426178 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[3].display_name | Pharmacology |
| concepts[4].id | https://openalex.org/C3020225094 |
| concepts[4].level | 3 |
| concepts[4].score | 0.412860244512558 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q80091 |
| concepts[4].display_name | Area under curve |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.40306997299194336 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3856261074542999 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3659953773021698 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.3632775545120239 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.35710281133651733 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C112705442 |
| concepts[10].level | 2 |
| concepts[10].score | 0.2638447880744934 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q323936 |
| concepts[10].display_name | Pharmacokinetics |
| concepts[11].id | https://openalex.org/C41008148 |
| concepts[11].level | 0 |
| concepts[11].score | 0.13653290271759033 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[11].display_name | Computer science |
| concepts[12].id | https://openalex.org/C77088390 |
| concepts[12].level | 1 |
| concepts[12].score | 0.11542254686355591 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8513 |
| concepts[12].display_name | Database |
| keywords[0].id | https://openalex.org/keywords/table |
| keywords[0].score | 0.5015311241149902 |
| keywords[0].display_name | Table (database) |
| keywords[1].id | https://openalex.org/keywords/area-under-the-curve |
| keywords[1].score | 0.49828052520751953 |
| keywords[1].display_name | Area under the curve |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.45641687512397766 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/pharmacology |
| keywords[3].score | 0.4397064745426178 |
| keywords[3].display_name | Pharmacology |
| keywords[4].id | https://openalex.org/keywords/area-under-curve |
| keywords[4].score | 0.412860244512558 |
| keywords[4].display_name | Area under curve |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.40306997299194336 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.3856261074542999 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.3659953773021698 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.3632775545120239 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.35710281133651733 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/pharmacokinetics |
| keywords[10].score | 0.2638447880744934 |
| keywords[10].display_name | Pharmacokinetics |
| keywords[11].id | https://openalex.org/keywords/computer-science |
| keywords[11].score | 0.13653290271759033 |
| keywords[11].display_name | Computer science |
| keywords[12].id | https://openalex.org/keywords/database |
| keywords[12].score | 0.11542254686355591 |
| keywords[12].display_name | Database |
| language | en |
| locations[0].id | doi:10.1158/2159-8290.26134819 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2159-8290.26134819 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5085217090 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2961-1142 |
| authorships[0].author.display_name | Matheus Henrique Dias |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Matheus Henrique Dias |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5090302884 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9845-3715 |
| authorships[1].author.display_name | Anoek Friskes |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Anoek Friskes |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5009783386 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0810-8828 |
| authorships[2].author.display_name | Siying Wang |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Siying Wang |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5079694182 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0549-8835 |
| authorships[3].author.display_name | João M. Fernandes Neto |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Joao M. Fernandes Neto |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5102915373 |
| authorships[4].author.orcid | https://orcid.org/0009-0000-6076-9469 |
| authorships[4].author.display_name | Frank van Gemert |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Frank van Gemert |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5056948757 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-6920-2696 |
| authorships[5].author.display_name | Soufiane Mourragui |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Soufiane Mourragui |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5061571526 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Chrysa Papagianni |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Chrysa Papagianni |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5049897931 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1015-4607 |
| authorships[7].author.display_name | Hendrik J. Kuiken |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Hendrik J. Kuiken |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5005545073 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7255-6153 |
| authorships[8].author.display_name | Sara Mainardi |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Sara Mainardi |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5076778474 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2585-622X |
| authorships[9].author.display_name | Daniel Álvarez‐Villanueva |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Daniel Alvarez-Villanueva |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5084927840 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-2754-4150 |
| authorships[10].author.display_name | Cor Lieftink |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Cor Lieftink |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5044639892 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9850-6071 |
| authorships[11].author.display_name | Ben Morris |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ben Morris |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5051328586 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-1000-3788 |
| authorships[12].author.display_name | Anna Dekker |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Anna Dekker |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5043411351 |
| authorships[13].author.orcid | https://orcid.org/0009-0004-1595-2327 |
| authorships[13].author.display_name | Emma van Dijk |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Emma van Dijk |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5023532676 |
| authorships[14].author.orcid | https://orcid.org/0009-0000-1795-6752 |
| authorships[14].author.display_name | Lieke H.S. Wilms |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Lieke H.S. Wilms |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5044344396 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-4203-9299 |
| authorships[15].author.display_name | Marcelo S. da Silva |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Marcelo S. da Silva |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5000562650 |
| authorships[16].author.orcid | https://orcid.org/0009-0001-7272-234X |
| authorships[16].author.display_name | Robin A. Jansen |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Robin A. Jansen |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5047045246 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-1668-7022 |
| authorships[17].author.display_name | Antonio Mulero‐Sánchez |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Antonio Mulero-Sánchez |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5055213329 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-8529-8234 |
| authorships[18].author.display_name | Elke Malzer |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Elke Malzer |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5003826728 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-5727-2099 |
| authorships[19].author.display_name | August Vidal |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | August Vidal |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5060569859 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-9854-5097 |
| authorships[20].author.display_name | Cristina Santos |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Cristina Santos |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5035175323 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-9419-6232 |
| authorships[21].author.display_name | Ramón Salazar |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Ramón Salazar |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5037639617 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-4909-9657 |
| authorships[22].author.display_name | Rosangela A.M. Wailemann |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Rosangela A.M. Wailemann |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5028091390 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-1425-9358 |
| authorships[23].author.display_name | Thompson E.P. Torres |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Thompson E.P. Torres |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5035090455 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-2647-228X |
| authorships[24].author.display_name | Giulia De Conti |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Giulia De Conti |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5022915602 |
| authorships[25].author.orcid | https://orcid.org/0000-0003-1759-8347 |
| authorships[25].author.display_name | Jonne A. Raaijmakers |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Jonne A. Raaijmakers |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5087708892 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-1086-8108 |
| authorships[26].author.display_name | Pétur Snæbjörnsson |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Petur Snaebjornsson |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5022374609 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-4883-0156 |
| authorships[27].author.display_name | Shengxian Yuan |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Shengxian Yuan |
| authorships[27].is_corresponding | False |
| authorships[28].author.id | https://openalex.org/A5030429117 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-1989-3027 |
| authorships[28].author.display_name | Wenxin Qin |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Wenxin Qin |
| authorships[28].is_corresponding | False |
| authorships[29].author.id | https://openalex.org/A5112006097 |
| authorships[29].author.orcid | |
| authorships[29].author.display_name | John S. Kovach |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | John S. Kovach |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5072122806 |
| authorships[30].author.orcid | https://orcid.org/0000-0001-9557-0804 |
| authorships[30].author.display_name | Hugo A. Armelin |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Hugo A. Armelin |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5002551113 |
| authorships[31].author.orcid | https://orcid.org/0000-0003-0255-4042 |
| authorships[31].author.display_name | Hein te Riele |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Hein te Riele |
| authorships[31].is_corresponding | False |
| authorships[32].author.id | https://openalex.org/A5035202405 |
| authorships[32].author.orcid | https://orcid.org/0000-0002-9442-3551 |
| authorships[32].author.display_name | Alexander van Oudenaarden |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Alexander van Oudenaarden |
| authorships[32].is_corresponding | False |
| authorships[33].author.id | https://openalex.org/A5010924102 |
| authorships[33].author.orcid | https://orcid.org/0000-0001-9295-1951 |
| authorships[33].author.display_name | Haojie Jin |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | Haojie Jin |
| authorships[33].is_corresponding | False |
| authorships[34].author.id | https://openalex.org/A5058317809 |
| authorships[34].author.orcid | https://orcid.org/0000-0003-0116-4130 |
| authorships[34].author.display_name | Roderick L. Beijersbergen |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | Roderick L. Beijersbergen |
| authorships[34].is_corresponding | False |
| authorships[35].author.id | https://openalex.org/A5004386682 |
| authorships[35].author.orcid | https://orcid.org/0000-0001-5164-0006 |
| authorships[35].author.display_name | Alberto Villanueva |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | Alberto Villanueva |
| authorships[35].is_corresponding | False |
| authorships[36].author.id | https://openalex.org/A5074565662 |
| authorships[36].author.orcid | https://orcid.org/0000-0002-6754-0381 |
| authorships[36].author.display_name | René H. Medema |
| authorships[36].author_position | middle |
| authorships[36].raw_author_name | Rene H. Medema |
| authorships[36].is_corresponding | False |
| authorships[37].author.id | https://openalex.org/A5028266055 |
| authorships[37].author.orcid | https://orcid.org/0000-0001-8677-3423 |
| authorships[37].author.display_name | René Bernards |
| authorships[37].author_position | last |
| authorships[37].raw_author_name | Rene Bernards |
| authorships[37].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2159-8290.26134819 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Table S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12996 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9635999798774719 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1305 |
| primary_topic.subfield.display_name | Biotechnology |
| primary_topic.display_name | Cancer Research and Treatments |
| related_works | https://openalex.org/W3129055671, https://openalex.org/W2053081131, https://openalex.org/W2075569025, https://openalex.org/W3108466129, https://openalex.org/W2130905969, https://openalex.org/W2392162854, https://openalex.org/W3024816283, https://openalex.org/W2405447315, https://openalex.org/W2248642016, https://openalex.org/W205807182 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/2159-8290.26134819 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2159-8290.26134819 |
| primary_location.id | doi:10.1158/2159-8290.26134819 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2159-8290.26134819 |
| publication_date | 2024-07-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.6: | 2 |
| abstract_inverted_index.by | 34 |
| abstract_inverted_index.in | 8, 24, 37 |
| abstract_inverted_index.of | 19, 29 |
| abstract_inverted_index.or | 27 |
| abstract_inverted_index.AUC | 6, 39 |
| abstract_inverted_index.and | 42 |
| abstract_inverted_index.are | 32 |
| abstract_inverted_index.the | 13, 20, 25, 35, 38 |
| abstract_inverted_index.Area | 11 |
| abstract_inverted_index.drug | 4, 22 |
| abstract_inverted_index.each | 17 |
| abstract_inverted_index.from | 16 |
| abstract_inverted_index.(AUC) | 15 |
| abstract_inverted_index.Curve | 14 |
| abstract_inverted_index.Under | 12 |
| abstract_inverted_index.cells | 10 |
| abstract_inverted_index.table | 1 |
| abstract_inverted_index.SW-480 | 9 |
| abstract_inverted_index.ranked | 33 |
| abstract_inverted_index.screen | 23 |
| abstract_inverted_index.LB-100. | 30 |
| abstract_inverted_index.absence | 28 |
| abstract_inverted_index.between | 40 |
| abstract_inverted_index.screens | 5 |
| abstract_inverted_index.compound | 18 |
| abstract_inverted_index.presence | 26 |
| abstract_inverted_index.Compounds | 31 |
| abstract_inverted_index.untreated | 43 |
| abstract_inverted_index.difference | 36 |
| abstract_inverted_index.differences | 7 |
| abstract_inverted_index.LB-100-treated | 41 |
| abstract_inverted_index.Stress-focused | 3 |
| abstract_inverted_index.stress-focused | 21 |
| abstract_inverted_index.samples.</p> | 44 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 38 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.13974139 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |